136 related articles for article (PubMed ID: 10543935)
21. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
23. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
24. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
25. Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats.
Fernández E; Martín MA; Fajardo S; Escrivá F; Alvarez C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E187-95. PubMed ID: 16912057
[TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
27. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells.
Banerjee K; Mohr L; Wands JR; de la Monte SM
Alcohol Clin Exp Res; 1998 Dec; 22(9):2093-101. PubMed ID: 9884156
[TBL] [Abstract][Full Text] [Related]
28. Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line.
Sepp-Lorenzino L; Rosen N; Lebwohl DE
Cell Growth Differ; 1994 Oct; 5(10):1077-83. PubMed ID: 7848909
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
[TBL] [Abstract][Full Text] [Related]
30. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
Pandini G; Vigneri R; Costantino A; Frasca F; Ippolito A; Fujita-Yamaguchi Y; Siddle K; Goldfine ID; Belfiore A
Clin Cancer Res; 1999 Jul; 5(7):1935-44. PubMed ID: 10430101
[TBL] [Abstract][Full Text] [Related]
31. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
Lassarre C; Ricort JM
Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
33. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
34. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.
Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL
Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor I activates insulin receptor substrate 1 and Ras in human osteosarcoma cells.
Lopaczynski W; Terry C
Acta Biochim Pol; 1999; 46(1):117-23. PubMed ID: 10453987
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
Surmacz E; Burgaud JL
Clin Cancer Res; 1995 Nov; 1(11):1429-36. PubMed ID: 9815941
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
[TBL] [Abstract][Full Text] [Related]
38. Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.
Chernicky CL; Yi L; Tan H; Ilan J
Clin Breast Cancer; 2005 Oct; 6(4):340-8. PubMed ID: 16277885
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
Lee JS; Weiss J; Martin JL; Scott CD
Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway.
Chow JC; Condorelli G; Smith RJ
J Biol Chem; 1998 Feb; 273(8):4672-80. PubMed ID: 9468528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
